Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors

Publisher: Karger

E-ISSN: 1423-0232|91|5|251-260

ISSN: 0030-2414

Source: Oncology, Vol.91, Iss.5, 2016-09, pp. : 251-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract